Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: Interim analysis of a prospective, placebo-controlled, double-blind study

Critical Care Medicine

Volumn 28, Issue 11, 2000, Pages 3620-3625

  Pettilä, Ville ^a   Takkunen, Olli ^a   Varpula, Tero ^a   Markkola, Antti ^a   Porkka, Kimmo ^a   Valtonen, Ville ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adult respiratory distress syndrome; Colony stimulating; Filgrastim; Granulocyte; Intensive care; Multiple organ dysfunction; Nosocomial infection; Prevention; Randomized; Safety

Indexed keywords

PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL TRIAL; DRUG SAFETY; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; INTUBATION; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCORING SYSTEM; TREATMENT INDICATION;

EID: 0033678510     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200011000-00011     Document Type: Article

References (30)

1. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit
2. Multiple organ failure: Pathophysiology and potential future therapy
3. Multiple organ failure syndrome in the 1990's: Systemic inflammatory response and organ dysfunction
4. The prevalence of nosocomial infection in intensive care units in Europe
5. Preventing nosocomial pneumonia: State of art and perspectives for the 1990s
6. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy
7. Granulocyte colony-stimulating factor enhances the phagocytic and bacterial activity of normal and defective human neutrophils
8. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats
9. Potential role of granulocyte colony-stimulating factors in the prevention and treatment of infectious diseases
10. Granulocyte colony-stimulating factor treatment in intra-abdominal sepsis
11. Prophylactic and simultaneous administration of recombinant human granulocyte colony-stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats
12. Role of granulocyte-colony stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: An overview
13. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat
14. Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with bacteria
15. Phase 1 trial of filgrastim (r-metHug-CSF) in non-neutropenic patients with severe community-acquired pneumonia
16. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage
17. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in new-born infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia
18. Filgrastim in the treatment of hospitalized patients with community acquired pneumonia (CAP)
19. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome
20. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination
21. Ventilator associated pneumonia: A multivariate analysis
22. Definitions for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis
23. Bacteriuria in catheterized patients: What quantitative level of bacteriuria is relevant?
24. Lung neutrophils in the adult respiratory distress syndrome: Clinical and patho-physiological significance
25. Transient hypoxemia during neutrophil recovery in febrile patients
26. Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome
27. Safety of a low-dosage filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process
28. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults
29. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality
30. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis